News
AstraZeneca Plc plans to invest US$50bil in the United States before 2030, becoming the latest European pharma company to ...
Eli Lilly & Co. closed 20.16% below its 52-week high of $972.53, which the company achieved on August 22nd.
Pharmaceutical stocks are in focus as President Trump's drug tariff deadline looms. Yahoo Finance Senior Reporter Anjalee ...
AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...
With Richard Ayoade with David Letterman, Robert Downey Jr., Kamilah Forbes, Scott Galloway, Tom Hanks, Becky Kennedy, and ...
Kiran Musunuru, a University of Pennsylvania cardiologist and leading gene-editing researcher, thinks it’s possible. Musunuru cofounded Verve Therapeutics, a company developing a therapy that uses ...
Amy and Kameel each bring an extraordinary combination of strategic vision, operational excellence, and hands-on experience developing and commercializing therapies in complex neurological and chronic ...
The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...
Pharmaceutical giant Eli Lilly delivers strong financial results and has a deep lineup and pipeline. Much smaller Viking Therapeutics boasts several candidates whose progress could jolt its shares.
The best stocks to invest in often are industry leaders in vast markets. These five stocks are likely to continue making ...
AstraZeneca Plc plans to invest $50 billion in the US before 2030, ratcheting up spending alongside other European drugmakers ...
AstraZeneca on Monday announced plans to invest $50 billion in its US operations by 2030, a sweeping commitment that includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results